Literature DB >> 36241743

Stereotactic radiosurgery for recurrent pleomorphic adenoma of the lacrimal gland: a case report.

Motoyuki Umekawa1, Keita Saito1, Yuki Shinya2, Hirotaka Hasegawa1, Mariko Kawashima1, Yu Teranishi1, Atsuto Katano3, Masako Ikemura4, Nobuhito Saito1.   

Abstract

Lacrimal gland pleomorphic adenomas (LGPAs) are common, benign, and intraorbital tumours that cause exophthalmos, ptosis, and visual disturbances. The curative treatment for LGPAs is gross total resection, and radiotherapy is considered adjunctive for recurrence or an alternative for inoperable LGPAs. Stereotactic radiosurgery (SRS) can be used for precise delivery of high radiation doses to the tumour, crucial in the treatment of intra-and extracranial neoplasms. Here, we present a 95-year-old woman who had a rapidly growing, recurrent LGPA and was successfully treated with SRS. The tumour was controlled without any adverse events over 21 months following SRS. SRS is a potential alternative treatment for recurrent LGPA.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Austria, part of Springer Nature.

Entities:  

Keywords:  Case report; Lacrimal gland pleomorphic adenoma; Malignant transformation; Recurrence; Stereotactic radiosurgery

Year:  2022        PMID: 36241743     DOI: 10.1007/s00701-022-05384-7

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.816


  15 in total

1.  Risk of radiation retinopathy in patients with orbital and ocular lymphoma.

Authors:  Megha Kaushik; Jose S Pulido; Steven E Schild; Scott Stafford
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-05-15       Impact factor: 7.038

2.  Lacrimal gland pleomorphic adenoma: a review of 52 cases, 15-year experience.

Authors:  Pedro Clarós; Emmanuel Choffor-Nchinda; Marta Lopez-Fortuny; Aleksandra Zofia Sobolewska; Andres Clarós
Journal:  Acta Otolaryngol       Date:  2019-01-10       Impact factor: 1.494

3.  Malignant epithelial tumors of the lacrimal gland: a clinicopathologic study of 21 cases.

Authors:  R L Font; S L Smith; R G Bryan
Journal:  Arch Ophthalmol       Date:  1998-05

4.  Masses of the Lacrimal Gland: Evaluation and Treatment.

Authors:  Jane S Kim; Jason Liss
Journal:  J Neurol Surg B Skull Base       Date:  2021-02-18

5.  Pleomorphic adenoma of the parotid gland 1985-2010: A Danish nationwide study of incidence, recurrence rate, and malignant transformation.

Authors:  Simon Andreasen; Marianne H Therkildsen; Kristine Bjørndal; Preben Homøe
Journal:  Head Neck       Date:  2015-09-18       Impact factor: 3.147

6.  Long-term risk of recurrence after intact excision of pleomorphic adenomas of the lacrimal gland.

Authors:  Zanna I Currie; Geoffrey E Rose
Journal:  Arch Ophthalmol       Date:  2007-12

Review 7.  Salivary gland pleomorphic adenoma.

Authors:  William M Mendenhall; Charles M Mendenhall; John W Werning; Robert S Malyapa; Nancy P Mendenhall
Journal:  Am J Clin Oncol       Date:  2008-02       Impact factor: 2.339

8.  Radiotherapy for pleomorphic adenoma of the parotid gland.

Authors:  J Barton; N J Slevin; E N Gleave
Journal:  Int J Radiat Oncol Biol Phys       Date:  1992       Impact factor: 7.038

9.  Pleomorphic adenocarcinoma of the lacrimal gland with multiple intracranial and spinal metastases.

Authors:  Jung Yong Ahn; Jong Hee Chang; Se Hoon Kim; Kyu Sung Lee
Journal:  World J Surg Oncol       Date:  2007-03-07       Impact factor: 2.754

Review 10.  Pleomorphic adenoma of the lacrimal gland: A review with updates on malignant transformation and molecular genetics.

Authors:  William Harrison; Patricia Pittman; Thomas Cummings
Journal:  Saudi J Ophthalmol       Date:  2018-03-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.